StonvexLoading…
StonvexStonvexStonvexCore line items from TRGP's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 | Annual 2021 2021-12-31 |
|---|---|---|---|---|
Revenue | $14.14B | $13.52B | $19.82B | $16.09B |
Operating Income | $2.70B | $2.63B | $1.73B | $864.80M |
Net Income | $1.31B | $1.35B | $1.20B | $71.20M |
EPS (Diluted) | $5.74 | $3.66 | $3.88 | $-0.07 |
Total Assets | $22.73B | $20.67B | $19.56B | $15.21B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $157.30M | $141.70M | $219.00M | $158.50M |
Free Cash Flow OCF − CapEx | $683.90M | $826.20M | $1.05B | $1.80B |
Shares Outstanding | 217.76M | 222.61M | 226.04M | 228.22M |